Ullmann Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 179.67%
(FY 2022)
- Profit -88.76%
(FY 2022)
- Ebitda -12.21%
(FY 2022)
- Net Worth 4.83%
(FY 2022)
- Total Assets 20.89%
(FY 2022)
About Ullmann Laboratories
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saleem Shaikh and Noorjhan Shaikh serve as directors at the Company.
- CIN/LLPIN
U85100MH2010PTC202922
- Company No.
202922
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationAurangabad, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ullmann Laboratories Private Limited offer?
Ullmann Laboratories Private Limited offers a wide range of products and services, including Chemical Intermediates, Fragrances, Fragrance Chemicals, Coumarin, Industrial Chemicals, Isobutyl Chloride, Ketones, Propiophenone, Speciality Chemicals, Alcohol Solvents.
Who are the key members and board of directors at Ullmann Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saleem Shaikh  | Director | 10-May-2010 | Current |
| Noorjhan Shaikh | Director | 10-May-2010 | Current |
Financial Performance of Ullmann Laboratories.
Ullmann Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 179.67% increase. The company also saw a substantial fall in profitability, with a 88.76% decrease in profit. The company's net worth moved up by a moderate rise of 4.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ullmann Laboratories?
In 2021, Ullmann Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ullmann Laboratories?
Unlock and access historical data on people associated with Ullmann Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ullmann Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ullmann Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
